It is a trading private limited company based in New Delhi, Delhi, India, established in 2012.
2012 | New Delhi, Delhi, India | ActiveNovorem Pharmaceuticals Private Limited, a active private limited company, was established on 28 December 2012 in New Delhi, Delhi, India. Engaging in other wholesale within the trade sector, it holds CIN: U51397DL2012PTC246789. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Samiullah Khan (Managing Director), Fatima (Whole-Time Director). Past directors included Nargis Khan, Fatima. It holds ₹9.90 M open charges and no settled loans. Its latest AGM occurred on 30 July 2025, with the balance sheet filed on 31 March 2025. It is based at B-10, Choudhary Complex D-54, Main Road, Batla House, Jamia Naga, R,, New Delhi, Delhi, 110025.
U51397DL2012PTC246789
246789
28 December 2012
₹0.50 M
₹0.50 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Novorem Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Samiullah Khan | Managing Director | 28 Dec 2012 | Current |
| Fatima | Whole-Time Director | 14 Sep 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 14 Sep 2018 | Past |
| Pramod Abcsdd | Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Novorem Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Novorem Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹9,900,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jan 2020 | Canara Bank | ₹9.90 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Novorem Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Novorem Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novorem Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Novorem Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Jul 2025 as per latest MCA records. was recorded as a recent event.
A charge with Canara Bank of Rs. 9.90 M registered on 29 Jan 2020 with Charge ID 100326414 was modified on 18 Jul 2025. was recorded as a recent event.
Novorem Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
Progress on A charge with Canara Bank amounted to Rs. 9.90 M with Charge ID 100326414 was registered on 29 Jan 2020. was documented.
Fatima was appointed as a Whole-time director was appointed as a Whole-time director on 14 Sep 2018 & has been associated with this company since 7 years 3 months . was recorded as a recent event.
The activity Samiullah Khan was appointed as a Managing Director was appointed as a Managing Director on 28 Dec 2012 & has been associated with this company since 12 years 11 months . was completed.
The CIN of Novorem Pharmaceuticals Private Limited is U51397DL2012PTC246789.
Novorem Pharmaceuticals Private Limited is headquartered at B-10, Choudhary Complex D-54, Main Road, Batla House, Jamia Naga, R,, New Delhi, Delhi, 110025.
Novorem Pharmaceuticals Private Limited was incorporated on 28 December 2012.
The current directors of Novorem Pharmaceuticals Private Limited are
The primary industry of Novorem Pharmaceuticals Private Limited is Trade.
Novorem Pharmaceuticals Private Limited is unlisted.
The authorized capital of Novorem Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Novorem Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX